Manchester United's unexpected decision to back out of a €45 million transfer deal for Atalanta midfielder Ederson has sent ripples through the football world. The club cited concerns over the player's right knee health, a move that has left Atalanta questioning the assessment and considering its options for their key player. This situation highlights the rigorous medical scrutiny in elite football transfers and the potential impact on both clubs and players.
Manchester United's Ederson Acquisition Falls Through Amidst Medical Concerns
In July 2026, a highly anticipated transfer saga involving Manchester United and Atalanta midfielder Ederson took an unexpected turn. The Red Devils, after initially agreeing to a €45 million deal and securing preliminary agreements with both the player and his current club, decided to withdraw their offer. The primary reason for this abrupt change was the outcome of the second phase of Ederson's medical examinations conducted in Manchester.
According to reports from Gazzetta, Manchester United's medical staff expressed reservations about the condition of Ederson's right knee. They determined that his knee did not meet the stringent athletic standards required for Premier League competition. This finding came despite Ederson having undergone arthroscopic surgery on his right meniscus in August of the previous year. Following his recovery, the Brazilian midfielder had an impressive season with Atalanta, accumulating 3,169 minutes of play across all competitions, including 30 appearances in Serie A and nine in the Champions League. He was, in fact, the fourth most utilized outfield player for La Dea last season, a statistic that Atalanta believes unequivocally demonstrates his full fitness.
Atalanta has publicly stood by their player, asserting that Ederson is in excellent physical condition, regardless of Manchester United's assessment. This disagreement leaves Atalanta in a challenging position, as Ederson's contract is set to expire in 2027. The club now faces the prospect of either offering him a new, improved deal to secure his future or actively seeking other clubs interested in acquiring his services in the upcoming transfer windows.
Further complicating matters, some Italian media outlets speculate that Manchester United's decision might also be influenced by the standout performances of Roma's Manu Koné at the recent World Cup. It is suggested that the Red Devils might now be pivoting their attention towards signing the Frenchman instead. However, Corriere dello Sport reports that Roma would demand a transfer fee of at least €55 million for Koné, a figure significantly higher than the initial agreement for Ederson.
The collapsed deal underscores the complexities and high stakes involved in professional football transfers, where medical assessments can drastically alter the trajectory of a player's career and a club's strategic planning.
The sudden collapse of Ederson's transfer to Manchester United serves as a stark reminder of the rigorous and often unforgiving nature of professional sports, particularly concerning player health. It highlights how even seemingly minor medical concerns, or differing interpretations of medical reports, can derail multi-million dollar deals. From a player's perspective, it underscores the constant pressure to maintain peak physical condition and the vulnerability to unforeseen setbacks, while for clubs, it emphasizes the need for thorough due diligence and flexible transfer strategies. This incident may also prompt further discussions within the football community regarding the standardization of medical evaluations and the transparency of injury histories in future transfer negotiations.
